The Hindu Business Line : Natco Pharma net higher at Rs 13.08 cr

NATCO Pharma Ltd (NPL) has registered a growth of over 28 per cent in turnover, 67 per cent in profit before tax and write offs and 154 per cent in net profit during the fiscal ended March 2004.

The company has reported a turnover of Rs 153.82 crore compared with Rs 119.86 crore in the previous fiscal and recorded a profit before tax and write offs of Rs 19.2 crore (Rs 11.48 crore) and a net profit of Rs 13.08 crore (Rs 5.15 crore).The EPS has improved to Rs 5.59 from Rs 2.96 on the expanded equity base of Rs 23.38 crore (Rs 17.38 crore), while the reserves have more than doubled to reach Rs 57.83 crore (Rs 24.08 crore).

The company has incurred a total expenditure of Rs 117.05 crore (Rs 89.82 crore) and provided Rs 12.78 crore towards interest (Rs 14.32 crore), Rs 4.77 crore towards depreciation (Rs 4.24 crore), Rs 5.2 crore towards provisions and write offs (Rs 6.14 crore) and Rs 92 lakh towards taxation (Rs 19 lakh).

Of the total revenue for the year, the company has achieved Rs 81.27 crore from bulk chemicals (Rs 62.49 crore), Rs 59.15 crore from formulations (Rs 35.83 crore), Rs 8.76 crore from job works (Rs 11.97 crore) and Rs 9.54 crore from others (Rs 10.25 crore).

According to the segment results, the company has achieved a profit of Rs 35.09 crore from bulk chemicals (Rs 20 crore) and suffered a loss of Rs 2.83 crore in formulations compared to a profit of Rs 2.34 crore in the previous fiscal.